Replimune Group, Inc. (REPL) Misses Q2 EPS by 5c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.79), $0.05 worse than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FirstCash to acquire UK pawn operator Ramsdens for £206 million
• Robinhood prices $2B convertible notes offering due 2029